Abstract
An increased occurrence of complicated parapneumonic effusions in children has been reported from the UK and USA. Data from mainland Europe are scarce. We investigated the incidence of complicated parapneumonic effusion and empyaema in children admitted to the University Hospital of Leuven between 1993 and 2005, an era when pneumococcal conjugated vaccination had not yet been implemented. Sixty-eight cases were identified. The incidence increased from 20–55/100,000 hospital admissions to 120–130/100,000 hospital admissions in 2005, with 50% of the cases occurring from 2003 onwards (late cohort). This increase occurred later than that reported in the UK and US, but is of similar magnitude. The median patient age was 3.6 years (range 0.5–17 years). The median duration of symptoms before admission was 4 days (quartile values 3–7 days). The median white blood cell (WBC) count was 15,450 WBC/mm3 (quartile values 11,300–21,200 WBC/mm3) and the median C-reactive protein (CRP) level was 242 mg/L (quartile values 143–344 mg/L). Patients in the late cohort seemed to have worse disease compared to early cohort patients; significantly higher pleural lactate dehydrogenase (LDH) level (P = 0,02), higher pleural WBC, lower pleural glucose level and significantly longer duration of hospitalisation in the later cohort (P < 0,05), possibly reflecting more severe disease. In both cohorts, Streptococcus pneumoniae was the most frequently isolated pathogen, with serogroup 1 prevailing. The occurrence of complicated parapneumonic effusion increased in Belgian children before pneumococcal vaccination was added to routine childhood immunisations. This increase is pronounced from 2003 onwards (late cohort) and, thus, occurred later than that reported in the UK and USA; several parameters point towards the occurrence of more serious disease in the late cohort patients.
Similar content being viewed by others
Abbreviations
- WBC:
-
White blood cell
- CRP:
-
C-reactive protein
- VATS:
-
Video-assisted thoracoscopic surgery
References
Balfour-Lynn IM, Abrahamson E, Cohen G, Hartley J, King S, Parikh D, Spencer D, Thomson AH, Urguhart D; Paediatric Pleural Diseases Subcommittee of the BTS Standards of Care Committee (2005) BTS guidelines for the management of pleural infection in children. Thorax 60(Suppl 1):i1–i21
Bekri H, Cohen R, Varon E, Madhi F, Gire R, Guillot F, Delacourt C (2007) Streptococcus pneumoniae serotypes involved in children with pleural empyemas in France. Arch Pediatr 14(3):239–243
Buckingham SC, King MD, Miller ML (2003) Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001. Pediatr Infect Dis J 22:499–504
Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason EO (2006) Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 25:250–254
Byington CL, Spencer LY, Johnson TA, Pavia AT, Allen D, Mason EO, Kaplan S, Carroll KC, Daly JA, Christenson JC, Samore MH (2002) An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 34:434–440
Chonmaitree T, Powell KR (1983) Parapneumonic pleural effusion and empyema in children. Review of a 19-year experience, 1962–1980. Clin Pediatr (Phila) 22:414–419
Deiros Bronte L, Baquero-Artigao F, García-Miguel MJ, Hernández González N, Peña García P, del Castillo Martín F (2006) Parapneumonic pleural effusion: an 11-year review. An Pediatr (Barc) 64:40–45
Eastham KM, Freeman R, Kearns AM, Eltringham G, Clark J, Leeming J, Spencer DA (2004) Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 59:522–525
Fletcher M, Leeming J, Cartwright K, Finn A; South West of England Invasive Community Acquired Infection Study Group (2006) Childhood empyema: limited potential impact of 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 25:559–560
Gupta R, Crowley S (2006) Increasing paediatric empyema admissions. Thorax 61:179–180
Hardie WD, Bokulic R, Garcia VF, Reising SF, Christie CD (1996) Pneumococcal pleural empyemas in children. Clin Infect Dis 22:1057–1063
Hardie WD, Roberts NE, Reising SF, Christie CD (1998) Complicated parapneumonic effusions in children caused by penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics 101(3 Pt 1):388–392
Kim PE, Musher DM, Glezen WP, Rodriguez-Barrada MC, Nahm WK, Wright CE (1996) Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis 22:100–106
Light RW (1995) A new classification of parapneumonic effusions and empyema. Chest 108:299–301
O’Brien KL, Walters MI, Sellman J, Quinlisk P, Regnery H, Schwartz B, Dowell SF (2000) Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis 30:784–789
Peltola VT, McCullers JA (2004) Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J 23(1 Suppl):S87–S97
Playfor SD, Smyth AR, Stewart RJ (1997) Increase in incidence of childhood empyema. Thorax 52:932
Quadri A, Thomson AH (2002) Pleural fluids associated with chest infection. Paediatr Respir Rev 3:349–355
Rees JH, Spencer DA, Parikh D, Weller P (1997) Increase in incidence of childhood empyema in West Midlands, UK. Lancet 349:402
Schultz KD, Fan LL, Pinsky J, Ochoa L, Smith EO, Kaplan SL, Brandt ML (2004) The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 113:1735–1740
Sonnappa S, Cohen G, Owens CM, van Doorn C, Cairns J, Stanojevic S, Elliott MJ, Jaffé A (2006) Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med 174:221–227
Tan TQ, Mason EO Jr, Wald ER, Barson WJ, Schutze GE, Bradley JS, Givner LB, Yogev R, Kim KS, Kaplan SL (2002) Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics 110:1–6
Thomson AH, Hull J, Kumar MR, Wallis C, Balfour-Lynn IM (2002) Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax 57:343–347
Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A; Active Bacterial Core Surveillance of the Emerging Infections Program Network (2003) Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348:1737–1746
Acknowledgement
We thank Mrs. Trudy Havermans for her help with the statistical analysis.
Sources of support
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Tine Van Ackere and Marijke Proesmans contributed equally to this paper and are the first authors.
Rights and permissions
About this article
Cite this article
Van Ackere, T., Proesmans, M., Vermeulen, F. et al. Complicated parapneumonic effusion in Belgian children: increased occurrence before routine pneumococcal vaccine implementation. Eur J Pediatr 168, 51–58 (2009). https://doi.org/10.1007/s00431-008-0708-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-008-0708-z